With our portfolio of over 250 New Zealand startups and $270m assets under management, Icehouse Ventures is New Zealand’s most active early-stage investment firm.
The “best kept secret” in venture capital is that big companies emerge from small companies. As New Zealand’s most active early-stage investor since 2015, we are uniquely positioned to access and invest in today’s most promising emerging tech companies.
3.18 years is the average time between a first round and series A.
Snowball Effect has partnered with Icehouse Ventures as they complete their final close for their expansion fund - IVX - giving Kiwi investors a simple way to gain access and exposure to a portfolio of NZ’s leading technology startups.
Icehouse Ventures has recently launched IVX, a growth stage venture fund. A $50m first close has been completed, backed by a $20m cornerstone investment from Simplicity.
IVX will leverage our unique information, relationships, and pre-emptive rights that we have accumulated as a result of investing in 250 startups to date.
IVX will invest in 30 “late-stage” companies (Series A-D stage) that exhibit the following features: established and growing teams, well-developed products & services, evidence of competitive wins, five or more years in market, revenue & proven business models, robust governance, and importantly, the potential for significant global growth. This fund will be industry agnostic.
1% p/a on committed capital
20% over an 8% annually compounding hurdle
30 or more Series A-D stage NZ companies
We have funded over 250 companies since 2003 (150 in the last five years). We own 5% of 74 companies.
Pre-emptive rights provide access in competitive and oversubscribed rounds. We were among the only NZ investors to access First AML’s pre-Series A, Halter’s Series A, Joyous’ Series A, and Sunfed’s Series A.
Relationships with founders that span years, not months. These relationships often include residency in our co-working space, attendance at our invite-only gatherings and support of multiple capital raises.
Proprietary information. We can evaluate Series A capital raises in the context of years of reports, not just a pitch deck and DD room. In some instances we also have unique visibility by way of positions on Boards and access to financial accounts.
We have grown our access by launching a number of “NZ firsts” including:
Ice Angels has grown to over 200 investors, with $10m+ invested per year via our nominee.
Our “nominee as a service” to both active angels and companies has been well adopted.
Our Annual Showcase has scaled to 1,000 investors.
We continue to make 25+ new investments per year
Our seed funds currently have ~$35m to deploy
Why does this matter?
Our existing funds are not oriented towards follow on investment. IVX picks up where they leave off, and importantly it better positions our seed funds to attract the best companies.
30% allocated to Series A
70% concentrated into top performers
Investing in IVX Fund I provides a simple way for wholesale investors to get exposure to NZ VC opportunities. All investments will be held within Snowball Nominees, and will be available to view on Orchestra. Because the fund is a Limited Partnership, only wholesale investors are able to invest.
It's crucial for you to understand the characteristics and risks of this investment opportunity. New Zealand law normally requires people who offer financial products to provide in-depth information to investors before they invest. The usual rules do not apply to offers by companies through Snowball Effect. As a result, you may not be given all the information you need to make an informed decision. Investing is risky. Some of the key risks include loss of capital, illiquidity, lack of returns, dilution, loss of key people and customers, and lack of control. You should only invest money that you can afford to lose.